NCT03690778View on ClinicalTrials.gov

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 4, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2019

Conditions
DiabetesHyperlipidemias
Interventions
DRUG

"Metformin and Rosuvastatin seperately"

"administration of Metformin and Rosuvastatin seperately"

DRUG

JLP-1310

administration of JLP-1310

Trial Locations (1)

Unknown

Inha University Hospital, Incheon

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY

NCT03690778 - The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers. | Biotech Hunter | Biotech Hunter